+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Autism Spectrum Disorders Market Size by Type, Treatment Approach, by Geographic Scope And Forecast

  • ID: 5301533
  • Report
  • February 2020
  • Region: Global
  • 90 pages
  • Verified Market Research
1 of 4

FEATURED COMPANIES

  • Allergan
  • AstraZeneca
  • Behavior Innovations
  • Bristol Myers Squibb
  • Hopebridge LLC
  • Pfizer Inc
  • MORE
Autism Spectrum Disorders Market Size And Forecast

Autism Spectrum Disorders Market was valued at USD 3.42 Billion in 2020 and is projected to reach USD 4.59 Billion by 2027, growing at a CAGR of 4.28% from 2020 to 2027.

Global Autism Spectrum Disorders Market Overview

The rising prevalence of patients with Autism Spectrum Disorders (ASD) has been the biggest driver of the market. Better public and medical awareness along with improved possibilities of diagnosing children at a young age have led to an increase in the prevalence of ASD. According to the data published in March 2020 by the Centers for Disease Control and Prevention (CDC)’s Autism and Developmental Disabilities Monitoring (ADDM) Network, nearly 1 in every 54 8-year-old children were identified as having ASD in 2016.

Autism Spectrum Disorders Market Competitive Landscape

The “Global Autism Spectrum Disorders Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as Johnson & Johnson Services, Inc, Bristol Myers Squibb, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc, Roche Group, Allergan, Q BioMed Inc., AstraZeneca, Behavior Innovations, and Hopebridge, LLC.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan
  • AstraZeneca
  • Behavior Innovations
  • Bristol Myers Squibb
  • Hopebridge LLC
  • Pfizer Inc
  • MORE
1 Introduction
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Assumptions
1.5 Limitations

2 Research Methodology
2.1 Data Mining
2.2 Secondary Research
2.3 Primary Research
2.4 Subject Matter Expert Advice
2.5 Quality Check
2.6 Final Review
2.7 Data Triangulation
2.8 Bottom-Up Approach
2.9 Top Down Approach
2.1 Research Flow

3 Executive Summary
3.1 Market Overview
3.2 Global Autism Spectrum Disorders Market Geographical Analysis (Cagr %)
3.3 Global Autism Spectrum Disorders Market, by Type (Usd Million)
3.4 Global Autism Spectrum Disorders Market, by Treatment Approach (Usd Million)
3.5 Future Market Opportunities
3.6 Global Market Split

4 Market Outlook
4.1 Global Autism Spectrum Disorders Market Outlook
4.2 Market Drivers
4.2.1 Rising Prevalence of Patients Suffering With Asd
4.2.2 Growing Awareness and Initiative Programs
4.2.3 Increasing Government Funding
4.3 Market Restraint
4.3.1 High Asd-Associated Medical Costs
4.4 Market Opportunity
4.4.1 Ongoing Clinical Trials and Research Studies
4.5 Impact of Covid-19 on Autism Spectrum Disorders Market

5 Market, by Type
5.1 Overview
5.2 Autistic Disorder
5.3 Asperger Syndrome
5.4 Pdd-Nos
5.5 Other Pervasive Developmental Disorders

6 Market, by Treatment Approach
6.1 Overview
6.2 Behavioral Approaches
6.3 Early Intervention
6.4 Medication
6.5 Others

7 Market, by Geography
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia-Pacific
7.4.1 China
7.4.2 India
7.4.3 Japan
7.4.4 Rest of Asia-Pacific
7.5 Rest of World
7.5.1 Middle East and Africa
7.5.2 Latin America

8 Competitive Landscape
8.1 Overview
8.1 Competitive Scenario
8.2 Company Market Ranking Analysis

9 Company Profiles
9.1 Johnson & Johnson Services, Inc
9.1.1 Company Overview
9.1.2 Company Insights
9.1.3 Segment Breakdown
9.1.4 Product Benchmarking
9.1.5 SWOT Analysis
9.2 Bristol Myers Squibb
9.2.1 Company Overview
9.2.2 Company Insights
9.2.3 Segment Breakdown
9.2.4 Product Benchmarking
9.2.5 SWOT Analysis
9.3 Otsuka Pharmaceutical Co. Ltd
9.3.1 Company Overview
9.3.2 Company Insights
9.3.3 Product Benchmarking
9.3.4 SWOT Analysis
9.4 Pfizer, Inc
9.4.1 Company Overview
9.4.2 Company Insights
9.4.3 Segment Breakdown
9.4.4 Product/ Research Benchmarking
9.5 Roche Group
9.5.1 Company Overview
9.5.2 Company Insights
9.5.3 Segment Breakdown
9.5.4 Product Benchmarking
9.6 Astrazeneca
9.6.1 Company Overview
9.6.2 Company Insights
9.6.3 Segment Breakdown
9.6.4 Product/Research Benchmarking
9.7 Allergan
9.7.1 Company Overview
9.7.2 Company Insights
9.7.3 Segment Breakdown
9.7.4 Product/ Research Benchmarking
9.8 Q Biomed Inc.
9.8.1 Company Overview
9.8.2 Company Insights
9.8.3 Product Benchmarking
9.8.4 Key Development
9.9 Behavioral Innovations
9.9.1 Company Overview
9.9.2 Company Insights
9.9.3 Product Benchmarking
9.9.4 Key Development
9.10 Hopebridge, LLC
9.10.1 Company Overview
9.10.2 Company Insights
9.10.3 Product Benchmarking
9.10.4 Key Development
Note: Product cover images may vary from those shown
3 of 4
  • Johnson & Johnson Services Inc
  • Bristol Myers Squibb
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc
  • Roche Group
  • Allergan
  • Q BioMed Inc.
  • AstraZeneca
  • Behavior Innovations
  • Hopebridge LLC
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll